Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial

H pylori eradication significantly reduces the incidence of MGC after ER of gastric tumors and should be considered for H pylori-positive gastric tumor patients treated with ER. (Clinical trial registration number: NCT01510730.)